MedPath

Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial

Phase 3
Completed
Conditions
Transfusion
Age of Blood
Interventions
Other: Blood transfusion
Registration Number
NCT01638416
Lead Sponsor
Australian and New Zealand Intensive Care Research Centre
Brief Summary

In Australia, blood for transfusion has a "use by" date of 42 days after collection. The actual age of blood given to patients depends on what is available at the time and the rate of usage. During the last decade, it has been reported that blood transfusion in patients admitted to intensive care was associated with an independent increase of mortality. Some research suggests that transfusion of fresher blood might help patients in the intensive care unit to reach a better recovery. This project will test whether patients who receive 'fresher' blood do better than patients who receive 'standard issue' blood.

Detailed Description

Inclusion criteria

•Patients hospitalised in ICU with an anticipated ICU stay of at least 24 hours, in whom the decision has been made by medical staff to transfuse at least one RBC unit.

Exclusion criteria

* Age younger than 18

* Previous RBC transfusion during the current hospital admission (including transfusion in another hospital for transferred patients)

* Diagnosis of transplantation or hematologic diseases

* Pregnancy

* Cardiac surgery during the present hospital admission

* Expected to die imminently (\<24hrs)

* The treating physician believes it is not in the best interest of the patient to be randomised in this trial.

* Known objection to the administration of human blood products

* Participation in a competing study

Primary outcome- 90 day mortality

Secondary outcomes

1. 28 day mortality

2. Persistent Organ Dysfunction combined with death at 28

3. Days alive and free of mechanical ventilation at day 90 post randomisation

4. Day alive and free of renal replacement therapy at day 90 post randomisation

5. Blood stream infection in ICU (post randomisation) defined using the Center for Disease Control and Prevention/National Healthcare Safety Network criteria

6. Length of stay in ICU and in hospital post randomisation

7. Febrile non-haemolytic transfusion reactions

8. EQ-5D score at Day 90 post randomisation

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4994
Inclusion Criteria
  • Patients hospitalised in ICU with an anticipated ICU stay of at least 24 hours, in whom the decision has been made by medical staff to transfuse at least one RBC unit.
Exclusion Criteria
  • Age younger than 18
  • Previous RBC transfusion during the current hospital admission (including transfusion in another hospital for transferred patients)
  • Diagnosis of transplantation or hematologic diseases
  • Pregnancy
  • Cardiac surgery during the present hospital admission
  • Expected to die imminently (<24hrs)
  • The treating physician believes it is not in the best interest of the patient to be randomised in this trial.
  • Known objection to the administration of human blood products
  • Participation in a competing study (see below)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm BBlood transfusionBlood Transfusion Freshest blood.
Standard of careBlood transfusionBlood Transfusion Standard of care- oldest blood.
Primary Outcome Measures
NameTimeMethod
Mortality at Day 9090 Day

Mortality at Day 90

Secondary Outcome Measures
NameTimeMethod
Mortality at Day 2828 day

Mortality at day 28

Persistent Organ Dysfunction Combined With Death Measured at Day 28day 28

Persistent Organ Dysfunction combined with death measured at day 28

Days Alive and Free of Mechanical Ventilationday 28

Days alive and free of mechanical ventilation

Length of Stay in ICU and in Hospital Post Randomisation (Days)Median duration in ICU- short term storage group 4.2 Days (2.0 - 9.3), long term storage group 4.2 Days (1.9 - 9.4). Median duration in Hospital- short term storage group was 14.5 days (7.4 - 27.5), long term storage group was 14.7 days(7.4 - 28.3)

Median duration in ICU - short term storage group was 4.2 (2.0 - 9.3), long term storage group was 4.2 (1.9 - 9.4) Median duration in Hospital - short term storage group was 14.5 (7.4 - 27.5), long term storage group was 14.7 (7.4 - 28.3) In Days

Day Alive and Free of Renal Replacement Therapy.day 28

Day alive and free of renal replacement therapy.

Blood Stream Infection in ICU (Post Randomisation)While in ICU-Median duration in ICU - short term storage group was 4.2 days (2.0 - 9.3), long term storage group was 4.2 days (1.9 - 9.4)

Blood stream infection in ICU (post randomisation) Time Frame is in Days

Proportion of Patients Who Suffer at Least One Febrile Non-haemolytic Transfusion Reaction in ICUWhile in ICU-Median duration in ICU - short term storage group was 4.2 days (2.0 - 9.3), long term storage group was 4.2 days (1.9 - 9.4)

Proportion of patients who suffer at least one febrile non-haemolytic transfusion reaction in ICU

EuroQol-5Dimension 5 Level (EQ-5D-5L) Score at Day 180 Post RandomisationDay 180

EuroQol-5Dimension 5 level (EQ-5D-5L) score at day 180 post randomisation - not reported yet

Trial Locations

Locations (59)

Knox Private Hospital

🇦🇺

Melbourne, Australia

Monash Medical Centre

🇦🇺

Melbourne, Australia

Northern Hospital

🇦🇺

Melbourne, Australia

Royal Melbourne Hospital

🇦🇺

Melbourne, Australia

Sunshine Hospital

🇦🇺

Melbourne, Australia

Western Hospital

🇦🇺

Melbourne, Australia

Calvary Mater Newcastle

🇦🇺

Newcastle, Australia

John Hunter Hospital

🇦🇺

Newcastle, Australia

Fiona Stanley Hospital

🇦🇺

Perth, Australia

St John of God Murdoch Hospital

🇦🇺

Perth, Australia

Blacktown Hospital

🇦🇺

Sydney, Australia

Royal Perth Hospital

🇦🇺

Perth, Australia

Nepean Hospital

🇦🇺

Sydney, Australia

Prince of Wales Hospital

🇦🇺

Sydney, Australia

Epworth Hospital

🇦🇺

Richmond, Australia

Royal Prince Alfred Hospital

🇦🇺

Sydney, Australia

St George Hospital

🇦🇺

Sydney, Australia

Tamworth Hospital

🇦🇺

Tamworth, Australia

Wollongong Hospital

🇦🇺

Wollongong, Australia

St Vincent's University Hospital

🇮🇪

Dublin, Ireland

Limerick Regional Hospital

🇮🇪

Limerick, Ireland

Auckland City Hospital CVICU

🇳🇿

Auckland, New Zealand

Auckland City Hospital DCCM

🇳🇿

Auckland, New Zealand

Middlemore Hospital

🇳🇿

Auckland, New Zealand

Christchurch Hospital

🇳🇿

Christchurch, New Zealand

North Shore Hospital

🇳🇿

Auckland, New Zealand

Dunedin Hospital

🇳🇿

Dunedin, New Zealand

Waikato Hospital

🇳🇿

Hamilton, New Zealand

Nelson Hospital

🇳🇿

Nelson, New Zealand

King Abdulaziz Medical City

🇸🇦

Riyadh, Saudi Arabia

Wellington Hospital

🇳🇿

Wellington, New Zealand

Helsinki University Hospital

🇫🇮

Helsinki, Finland

Tampere University Hospital

🇫🇮

Tampere, Finland

Cork University Hospital

🇮🇪

Cork, Ireland

Beaumont Hospital

🇮🇪

Dublin, Ireland

St James's Hospital

🇮🇪

Dublin, Ireland

Galway Regional Hospital

🇮🇪

Galway, Ireland

St Vincent's Hospital

🇦🇺

Sydney, Australia

Albury Hospital

🇦🇺

Albury, Australia

Lyell McEwin Hospital

🇦🇺

Adelaide, Australia

The Alfred Hospital

🇦🇺

Melbourne, Victoria, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, Australia

Queen Elizabeth Hospital

🇦🇺

Adelaide, Australia

Bendigo Hospital

🇦🇺

Bendigo, Australia

Logan Hospital

🇦🇺

Brisbane, Australia

Mater Private Hospital

🇦🇺

Brisbane, Australia

Mater Adult Hospital

🇦🇺

Brisbane, Australia

Princess Alexandra Hospital

🇦🇺

Brisbane, Australia

Calvary Health

🇦🇺

Canberra, Australia

Canberra Hospital

🇦🇺

Canberra, Australia

Dandenong Hospital

🇦🇺

Dandenong, Australia

Geelong Hospital

🇦🇺

Geelong, Australia

Royal Brisbane and Women's Hospital

🇦🇺

Brisbane, Australia

Gold Coast Hospital

🇦🇺

Gold Coast, Australia

Gosford Hospital

🇦🇺

Gosford, Australia

Royal Hobart Hospital

🇦🇺

Hobart, Australia

Austin Hospital

🇦🇺

Heidelberg, Australia

Cabrini Hospital

🇦🇺

Melbourne, Australia

Frankston Hospital

🇦🇺

Melbourne, Australia

© Copyright 2025. All Rights Reserved by MedPath